Transverse myelitis is a rare inflammatory disease. It is caused by inflammation of the spinal cord. Generally, transverse myelitis damages the insulating material covering nerve cell fibers (myelin).
Signs and symptoms of transverse myelitis include pain, weakness in arms or legs, abnormal sensations, and bladder & bowel problems. Patients suffering from transverse myelitis report coldness or burning, numbness, and tingling. The exact cause of transverse myelitis is unknown. According to PubMed studies, transverse myelitis can be caused by multiple sclerosis, autoimmune disorders, Devic's disease, and infections of the gastrointestinal tract. Major complications of transverse myelitis are sexual dysfunction, stiffness, tightness or painful spasms, depression, or anxiety.
Doctors or professionals can diagnose transverse myelitis based on medical history and tests. Common diagnostic tests for transverse myelitis are lumbar puncture (spinal tap), blood tests, and magnetic resonance imaging (MRI).
Rise in prevalence of transverse myelitis across the world is anticipated to drive the global transverse myelitis treatment market during the forecast period. A rise in government prioritization of drugs for rare disorders is also expected to propel the global market in the near future. Moreover, shortage of health care experts in Latin America and Middle East & Africa hampers the growth of the transverse myelitis treatment market in the regions. Nevertheless, increase in government funding for diagnostic procedures is likely to augment the transverse myelitis treatment market. Organizations supporting the treatment of this disease globally are the Genetic and Rare Diseases (GARD) Information Center, the NIH/National Institute of Neurological Disorders and Stroke, the Academy of Spinal Cord Injury Professionals, Inc., and the Transverse Myelitis Association.
The global transverse myelitis treatment market can be segmented based on treatment, end-user, and region. In terms of treatment, the market can be bifurcated into drugs and therapies. The drugs segment can be classified into intravenous steroids, antiviral medication, pain medication, and others. The therapies segment can be categorized into physical therapy, occupational therapy, and psychotherapy. Methylprednisolone and dexamethasone are the common steroids used for the treatment of transverse myelitis. Occupational therapy and physical therapy have been effective in some patients. Chronic pain is a common complication of transverse myelitis. Doctors recommend common pain relievers such as acetaminophen, naproxen and ibuprofen.
In terms of end-user, the global transverse myelitis treatment market can be divided into hospitals, special clinics, and others. The hospitals segment held significant share of the market in 2017.
Based on region, the global transverse myelitis treatment market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for major share of the global market in 2017, followed by Europe and Asia Pacific. The U.S. held significant share of the market in North America in terms of revenue. The transverse myelitis treatment market in Asia Pacific is growing rapidly due to increase in the number of patients suffering from the disorder. Better health care infrastructure, economic growth, rise in the number of insurance payers, expanding & developing private health care sector, and increase in awareness among people about transverse myelitis treatment are expected to propel the market in the region in the next few years. The transverse myelitis treatment market in Latin America and Middle East & Africa is projected to expand at a moderate growth rate from 2018 to 2026.
Key players operating in the global transverse myelitis treatment market include Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals, Inc., WOCKHARDT, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Baxter, Amerigen Pharmaceuticals Limited, and Novartis AG.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.